These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10937356)

  • 41. Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet.
    Escolà-Gil JC; Marzal-Casacuberta A; Julve-Gil J; Ishida BY; Ordóñez-Llanos J; Chan L; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 1998 Feb; 39(2):457-62. PubMed ID: 9580110
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endothelial lipase is less effective at influencing HDL metabolism in vivo in mice expressing apoA-II.
    Broedl UC; Jin W; Fuki IV; Millar JS; Rader DJ
    J Lipid Res; 2006 Oct; 47(10):2191-7. PubMed ID: 16877778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A polymorphism affecting apolipoprotein A-II translational efficiency determines high density lipoprotein size and composition.
    Doolittle MH; LeBoeuf RC; Warden CH; Bee LM; Lusis AJ
    J Biol Chem; 1990 Sep; 265(27):16380-8. PubMed ID: 2118905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Purification, characterization and reverse cholesterol transport of human serum apolipoprotein A-IV].
    Hu Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Aug; 14(4):273-9. PubMed ID: 1473215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibrilization in mouse senile amyloidosis is fibril conformation-dependent.
    Higuchi K; Kogishi K; Wang J; Chen X; Chiba T; Matsushita T; Hoshii Y; Kawano H; Ishihara T; Yokota T; Hosokawa M
    Lab Invest; 1998 Dec; 78(12):1535-42. PubMed ID: 9881953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice.
    Ostos MA; Conconi M; Vergnes L; Baroukh N; Ribalta J; Girona J; Caillaud JM; Ochoa A; Zakin MM
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1023-8. PubMed ID: 11397714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Human apolipoprotein A-IV].
    Bovard-Houppermans S
    Ann Biol Clin (Paris); 1994; 52(10):701-10. PubMed ID: 7747877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apolipoprotein A-I gene expression in transgenic mice.
    Walsh A; Ito Y; Breslow JL
    Biotechnology; 1991; 16():227-35. PubMed ID: 1901028
    [No Abstract]   [Full Text] [Related]  

  • 49. Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance.
    Castellani LW; Goto AM; Lusis AJ
    Diabetes; 2001 Mar; 50(3):643-51. PubMed ID: 11246886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotypic characterization of the Ath-1 gene controlling high density lipoprotein levels and susceptibility to atherosclerosis.
    LeBoeuf RC; Doolittle MH; Montcalm A; Martin DC; Reue K; Lusis AJ
    J Lipid Res; 1990 Jan; 31(1):91-101. PubMed ID: 2107272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apolipoprotein A-II, genetic variation on chromosome 1q21-q24, and disease susceptibility.
    Martín-Campos JM; Escolà-Gil JC; Ribas V; Blanco-Vaca F
    Curr Opin Lipidol; 2004 Jun; 15(3):247-53. PubMed ID: 15166779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The properties of HDL in genetically engineered mice.
    Schultz JR; Rubin EM
    Curr Opin Lipidol; 1994 Apr; 5(2):126-37. PubMed ID: 8044415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Free cholesterol deposition in the cornea of human apolipoprotein A-II transgenic mice with functional lecithin: cholesterol acyltransferase deficiency.
    Julve-Gil J; Ruiz-Pérez E; Casaroli-Marano RP; Marzal-Casacuberta A; Escolà-Gil JC; González-Sastre F; Blanco-Vaca F
    Metabolism; 1999 Apr; 48(4):415-21. PubMed ID: 10206431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microarray analysis identifies human apoA-I
    Ganzetti GS; Parolini C
    Exp Cell Res; 2023 Dec; 433(1):113826. PubMed ID: 37858836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha.
    Mamontova A; Séguret-Macé S; Esposito B; Chaniale C; Bouly M; Delhaye-Bouchaud N; Luc G; Staels B; Duverger N; Mariani J; Tedgui A
    Circulation; 1998 Dec; 98(24):2738-43. PubMed ID: 9851961
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High density lipoproteins and coronary heart disease.
    Barter PJ; Rye KA
    Atherosclerosis; 1996 Mar; 121(1):1-12. PubMed ID: 8678914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis, transport, and processing of apolipoproteins of high density lipoproteins.
    Stoffel W
    J Lipid Res; 1984 Dec; 25(13):1586-92. PubMed ID: 6442339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Somatic gene transfer of human ApoA-I inhibits atherosclerosis progression in mouse models.
    Benoit P; Emmanuel F; Caillaud JM; Bassinet L; Castro G; Gallix P; Fruchart JC; Branellec D; Denèfle P; Duverger N
    Circulation; 1999 Jan 5-12; 99(1):105-10. PubMed ID: 9884386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential tissue-specific expression of human apoA-I and apoA-II.
    Eggerman TL; Hoeg JM; Meng MS; Tombragel A; Bojanovski D; Brewer HB
    J Lipid Res; 1991 May; 32(5):821-8. PubMed ID: 1649244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reconstitution of lipoproteins. I. Lipid-protein interaction of high density apoproteins, purified apoA-I and apoA-II with dimyristoyl-lecithin and dimyristoyl-lecithin:cholesterol vesicles studied by isomeric spin-labelled lecithins.
    Vaughan DJ; Breckenridge WC; Stanacev NZ
    Can J Biochem; 1980 Jul; 58(7):581-91. PubMed ID: 6256037
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.